Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair restoration. RCH-01 is an autologous cell therapy utilizing dermal sheath cup (DSC) cells isolated from the hair follicle to treat androgenetic alopecia. RCS-01 is an autologous cell therapy utilizing non-bulbar dermal sheath (NBDS) cells, a type of fibroblast cell isolated from the hair follicle to repair and regenerate tissue. RCT-01 provides a source of collagen expressing cells to the site of injury, addressing the underlying cause of tendinosis. It has also developed an injection device, DermaPrecise, which improves the administration of its cell therapy products and certain other injectables.


TSXV:RP - Post by User

Post by RPINVESTOR1on Oct 14, 2021 10:55am
251 Views
Post# 34005061

Thoughts on the Dermal Injector

Thoughts on the Dermal InjectorI just visited my dermatologist for my annual check-up. The clinic where she works has a very good reputation in Canada. I was interested in getting her opinion on the dermal injector that Replicel is proposing to bring to the market. I told her that it is extremely precise and is capable of freezing the skin before the skin is injected with the soft filler (ie. botox, etc.).

The Doctor told me that the injector would only be of value if it improved outcomes and was cost effective. She stated that they are already very satisfied with the outcomes they achieve with their patients. After hearing this, I couldn't help but think of the Replicel dermal injector and a comment my Father used to make - "This is the case of a solution looking for a problem!"

I hope I am wrong!
<< Previous
Bullboard Posts
Next >>